Apellis Pharmaceuticals, Inc. (APLS)

21.86 -1.34 (-5.78%) USD  |  NASDAQ  |  Jan 13, 13:31
More

Apellis Pharmaceuticals Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Biogen, Inc. --
Amicus Therapeutics, Inc. --
Fortress Biotech, Inc. --
Ultragenyx Pharmaceutical, Inc. --
Fulcrum Therapeutics, Inc. --